Literature DB >> 2404866

Colloidal gold immunolabeling of immunoglobulin-binding sites and beta antigen in group B streptococci.

S E Coleman1, L J Brady, M D Boyle.   

Abstract

We have characterized the immunoglobulin A (IgA)-Fc-binding properties and beta-antigen expression of several strains of group B streptococci by using ultrastructural immunocytochemistry. Colloidal gold-labeled tracers were used with intact and sectioned bacteria in order to gain information regarding the location and distribution of cell surface and cytoplasmic IgA-Fc-binding molecules and beta antigen. Colloidal gold (5- or 15-nm particles) was conjugated to IgA to characterize IgA-binding properties and to IgG to test for IgG binding. Rabbit anti-beta antiserum was reacted with the bacteria and then with protein G labeled with 15-nm colloidal gold particles. A double-labeling technique was used for simultaneous localization of IgA-Fc- and anti-beta-antibody-binding properties on sectioned bacteria. The data corroborated previous results which indicated that (i) IgA-Fc-binding and IgA-Fc-nonbinding forms of beta antigen can be secreted by strains which do not express beta antigen on the cell surfaces (HG806, VC75); (ii) differences in levels of expression of beta antigen and/or IgA-Fc-binding proteins can be detected among various group B isolates; (iii) group B streptococci do not express human IgG-Fc-binding proteins; and (iv) not all forms of beta antigen are capable of binding human IgA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404866      PMCID: PMC258459          DOI: 10.1128/iai.58.2.332-340.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay.

Authors:  L J Brady; U D Daphtary; E M Ayoub; M D Boyle
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

2.  Enzyme-labeled type III bacterial Fc receptors. A versatile tracer for immunoassay.

Authors:  K J Reis; G O Von Mering; M A Karis; E L Faulmann; R Lottenberg; M D Boyle
Journal:  J Immunol Methods       Date:  1988-03-16       Impact factor: 2.303

3.  A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G.

Authors:  G Kronvall
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

4.  Detection of receptors for the Fc region of IgG on streptococci.

Authors:  K J Reis; E M Ayoub; M D Boyle
Journal:  J Immunol Methods       Date:  1983-04-15       Impact factor: 2.303

5.  Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus.

Authors:  K J Reis; E M Ayoub; M D Boyle
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Ibc proteins as serotype markers of group B streptococci.

Authors:  L Bevanger
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1983-08

Review 7.  Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci.

Authors:  J J Langone
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

8.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

9.  Purification and some properties of streptococcal protein G, a novel IgG-binding reagent.

Authors:  L Björck; G Kronvall
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

10.  A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen.

Authors:  G J Russell-Jones; E C Gotschlich; M S Blake
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  1 in total

1.  Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.

Authors:  J L Michel; L C Madoff; D E Kling; D L Kasper; F M Ausubel
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.